[HTML][HTML] Pyroptosis in inflammatory diseases and cancer

Z Rao, Y Zhu, P Yang, Z Chen, Y Xia, C Qiao, W Liu… - Theranostics, 2022 - ncbi.nlm.nih.gov
Pyroptosis is a lytic and inflammatory type of programmed cell death that is usually triggered
by inflammasomes and executed by gasdermin proteins. The main characteristics of …

[HTML][HTML] Liver fibrosis: therapeutic targets and advances in drug therapy

Z Tan, H Sun, T Xue, C Gan, H Liu, Y Xie… - Frontiers in cell and …, 2021 - frontiersin.org
Liver fibrosis is an abnormal wound repair response caused by a variety of chronic liver
injuries, which is characterized by over-deposition of diffuse extracellular matrix (ECM) and …

A multiancestry genome-wide association study of unexplained chronic ALT elevation as a proxy for nonalcoholic fatty liver disease with histological and radiological …

M Vujkovic, S Ramdas, KM Lorenz, X Guo, R Darlay… - Nature …, 2022 - nature.com
Nonalcoholic fatty liver disease (NAFLD) is a growing cause of chronic liver disease. Using
a proxy NAFLD definition of chronic elevation of alanine aminotransferase (cALT) levels …

[HTML][HTML] Pyroptosis in renal inflammation and fibrosis: current knowledge and clinical significance

Y Liu, H Lei, W Zhang, Q Xing, R Liu, S Wu, Z Liu… - Cell Death & …, 2023 - nature.com
Pyroptosis is a novel inflammatory form of regulated cell death (RCD), characterized by cell
swelling, membrane rupture, and pro-inflammatory effects. It is recognized as a potent …

Immunopathobiology and therapeutic targets related to cytokines in liver diseases

Y He, S Hwang, YA Ahmed, D Feng, N Li… - Cellular & molecular …, 2021 - nature.com
Chronic liver injury with any etiology can progress to fibrosis and the end-stage diseases
cirrhosis and hepatocellular carcinoma. The progression of liver disease is controlled by a …

[HTML][HTML] Interleukin‐18 signaling promotes activation of hepatic stellate cells in mouse liver fibrosis

J Knorr, B Kaufmann, ME Inzaugarat, TM Holtmann… - Hepatology, 2023 - journals.lww.com
Interleukin‐18 signaling promotes activation of hepatic stel... : Hepatology Interleukin‐18
signaling promotes activation of hepatic stellate cells in mouse liver fibrosis : Hepatology AASLD …

[HTML][HTML] Creatine alleviates doxorubicin-induced liver damage by inhibiting liver fibrosis, inflammation, oxidative stress, and cellular senescence

N Aljobaily, MJ Viereckl, DS Hydock, H Aljobaily… - Nutrients, 2020 - mdpi.com
Background: Treatment with the chemotherapy drug doxorubicin (DOX) may lead to
toxicities that affect non-cancer cells including the liver. Supplementing the diet with creatine …

[HTML][HTML] Macrophage function in the pathogenesis of non-alcoholic fatty liver disease: the mac attack

JR Oates, MC McKell, ME Moreno-Fernandez… - Frontiers in …, 2019 - frontiersin.org
Obesity is a prevalent predisposing factor to non-alcoholic fatty liver disease (NAFLD), the
most common chronic liver disease in the developed world. NAFLD spectrum of disease …

NLRP3 inflammasome in hepatic diseases: A pharmacological target

E Ramos-Tovar, P Muriel - Biochemical Pharmacology, 2023 - Elsevier
The NOD-like receptor family pyrin domain containing 3 (NLRP3) inflammasome pathway is
mainly responsible for the activation and release of a cascade of proinflammatory mediators …

[HTML][HTML] Crosstalk network among multiple inflammatory mediators in liver fibrosis

HJ Zhangdi, SB Su, F Wang, ZY Liang… - World journal of …, 2019 - ncbi.nlm.nih.gov
Liver fibrosis is the common pathological basis of all chronic liver diseases, and is the
necessary stage for the progression of chronic liver disease to cirrhosis. As one of …